Evidence map›Paper›PMID 37675351›Full record

ArticleFrontiers in nephrology2023

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors.

Aida Frías, Francisco Vargas, Justo Sandino, Raquel Berzal, Marta Rivero, Lucía Cordero, Teresa Cavero, Julián Segura, Florencio García, Eduardo Hernández and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Frontiers in nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Aida FríasDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Francisco VargasDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Justo SandinoDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Raquel BerzalDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Marta RiveroDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Lucía CorderoDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Teresa CaveroDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Julián SeguraDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Florencio GarcíaDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Eduardo HernándezDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Eduardo GutiérrezDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Pilar AuñónDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Irene ZamanilloDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Julio PascualDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Enrique MoralesDepartment of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Research Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The current definition of chronic kidney disease applied to patients over the age of 80 has increased the number of referrals to Nephrology. However not all of these patients may benefit from its assessment. This study aims to analyze the evolution of ≥80 years old patients referred to Nephrology. Methods: Single-center study including patients ≥80 years old with eGFR <60 mL/min/1,73m2 who were referred to Nephrology consultation for the first time. Clinical and analytical parameters were collected retrospectively 12 months before the visit, and prospectively at baseline, and 12 and 24 months after the initial visit. We divided patients into two groups based on annual eGFR loss: progressors (>5 mL/min/1.73m2) and non-progressors (≤5 mL/min/1,73m2). Results: A total of 318 patients were included, mean age was 84,9 ± 4 (80-97) years. Baseline serum creatinine was 1,65 ± 0,62 mg/dL, eGRF 35 (28-42) mL/min/1,73, and albumin/creatinine ratio 36 (7-229) mg/g. 55,7% of the patients met the definition of progressor at baseline (initial-progressors), 26,3% were progressors after a 12-month follow-up and 13,4% after 24 months. 21,2% and 11,4% of initial-progressors met this definition at 12 and 24 month follow up. The main risk factor for progression was albuminuria. No relationship was found between the nephrologist intervention and the evolution of renal function among initial non-progressors. Conclusion: Elderly patients who have stable renal function at the time of referral will continue to have stable renal function over the subsequent 24 months and thus may not need to be referred to a nephrologist.

Indexed as

albuminuriachronic kidney diseaseCKD-EPIelderlyestimated glomerular filtration rate

Identifiers

PMID37675351
PMCPMC10479568
OpenAlexW4318827404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.